WebDocket for Pfizer, Inc. v. Regor Therapeutics Inc., 3:22-cv-00190 — Brought to you by Free Law Project, a non-profit dedicated to creating high quality open legal information. WebFeb 4, 2024 · In 2024, Xiayang Qiu and Ming Zhong left Pfizer and founded Regor Therapeutics. According to Pfizer’s complaint, the duo started Regor in May 2024 — one month before leaving Pfizer in June 2024. In 2024, they filed a patent for a diabetes-and-obesity treatment that was “strikingly similar” to the one developed by Pfizer, according to …
Regor Therapeutics Stock Price, Funding, Valuation, Revenue
WebInstructions for use Sinupret recommends taking 2 drops or 50 drops of the drug three times a day. Dragee swallowed whole, without biting and squeezing a small volume of liquid. … WebWe are aware that a lawsuit was filed by Pfizer Inc. against us and some of our executives on February 2, 2024. ... About Regor Therapeutics Group. Regor Therapeutics Group is a clinical stage company dedicated to the discovery and development of innovative and clinically differentiated medicines by leveraging the proprietary rCARD TM ... brezner studio
Regor Therapeutics - Products, Competitors, Financials, …
WebDenied, denied, denied—and a countersuit. Denied, denied, denied—and a countersuit. That’s the response Regor Therapeutics has offered to Pfizer’s lawsuit claiming two former employees ... WebParties, docket activity and news coverage of federal case Pfizer, Inc. v. Regor Therapeutics Inc. et al, case number 3:22-cv-00190, from Connecticut Court. WebPipeline. We have since initiated over 15 discovery projects since the inception of Regor in June 2024. Our projects cover oncology, autoimmune and metabolic diseases areas with … breznay